PRESS ROOM
Press Releases
Senator Feinstein Urges Rumsfeld to Complete Lariam Study—Anti-malarial drug given to service members linked to permanent brain damage—, from Senator Feinstein’s office, January 21, 2005.
Veterans Affairs Alerts Clinics of Possible Long-term Dangers from Anti-Malarial Drug, from Senator Dianne Feinstein’s office [D – CA], July 14, 2004.
Senator Feinstein Urges Secretary Powell to Reassess Lariam Use by State Department Employees, from Senator Dianne Feinstein’s office, July 16, 2004.
Lariam Action USA to Brief US Senate Staff Members on Side Effects of Lariam, July 1, 2004
Senator Feinstein Urges CDC To Review Its Recommendations on Anti-Malarial Drug, from Senator Dianne Feinstein’s office, June 14, 2004.
Senator Feinstein urges Pentagon to step up efforts to track medical damage caused by anti-malarial drug, from Senator Dianne Feinstein’s office, June 2, 2004.
Senator Feinstein urges HHS to evaluate safety of Lariam use by Americans overseas, from Senator Dianne Feinstein’s office, May 24, 2004.
Casualties of War, Letter to the editor, letter 4, San Francisco Chronicle, March 20, 2004, B8.
A Bitter Pill Worth Swallowing? Letter to the editor, Washington Post, October 28, 2003, A22.
Neuropsychiatric Side Effects Confirmed by Latest Lariam Research, February 2001
Contact Mefloquine (Lariam) Action
You may contact Mefloquine (Lariam) Action at the following addresses:
Jeanne Lese
Mefloquine (Lariam) Action
64 El Pavo Real Circle
San Rafael, CA 94903-3521